Everolimus-eluting stent safer, more effective than paclitaxel-eluting stent
May 6th, 2010 - 1:15 pm ICT by ANILondon, May 6 (ANI): Everolimus-eluting stents demonstrate enhanced safety and efficacy in the treatment of de novo native coronary artery lesions when compared to paclitaxel-eluting stents, scientists have discovered.
Results from the SPIRIT IV clinical trial, which were first presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2009 scientific symposium, were published in the New England Journal of Medicine.
The trial, a large-scale multi-center study of nearly 4,000 patients in the U.S., also examined the differences in performance of the two stents in patients with diabetes.
“The data published in today’s New England Journal of Medicine, and first reported at TCT, demonstrate enhanced safety and efficacy of the everolimus-eluting stent compared to the paclitaxel-eluting stent in this large-scale study without routine angiographic follow-up. The study results also suggest that minimal late loss may be achieved with drug-eluting stents without sacrificing safety,” said principal investigator Gregg W. Stone, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons, Director of Cardiovascular Research and Education at the Center for Interventional Vascular Therapy at NewYork-Presbyterian Hospital/Columbia University Medical Center and Co-Director of the Medical Research and Education Division at the Cardiovascular Research Foundation. (ANI)
- Drug-eluting stents safer than bare-metal ones for heart patients - Sep 26, 2009
- Drug-eluting stents found to be superior in efficacy to bare metal stents Home - May 27, 2009
- Drug-eluting stents found to be superior in efficacy to bare metal stents - May 07, 2009
- Drug-eluting stents more effective, equally as safe as bare metal ones - Oct 16, 2008
- Drug-coated stents less risky for heart bypass patients - Jan 22, 2009
- Imaging techniques can identify plaques likely to cause heart attacks - Sep 25, 2009
- New way to treat heart blocks: Drug eluting balloon - Sep 18, 2011
- Drug-eluting stents safe for long-term use in angioplasty patients - Aug 19, 2010
- Drug-eluting stents safer and superior to bare metal stents - Mar 29, 2009
- Drug-eluting stent can treat coronary artery disease - Mar 14, 2009
- Drug-coated stents safer for bypass patients - Jan 22, 2009
- New York docs implant heart valves without open-heart surgery - Jan 08, 2009
- Oxygen-saturated blood can reduce heart muscle damage after an attack - Sep 16, 2009
- Drug-eluting stents as safe and effective than bare-metal ones - Nov 20, 2007
- Drug-eluting stents safer than metallic ones in preventing cardiac deaths - Mar 29, 2009
Tags: cardiovascular research foundation, college of physicians, college of physicians and surgeons, columbia university college, columbia university college of physicians and surgeons, columbia university medical, drug eluting stents, education division, england journal of medicine, journal of medicine, md professor, native coronary artery, new england journal, new england journal of medicine, paclitaxel, physicians and surgeons, presbyterian hospital, transcatheter cardiovascular therapeutics, university medical center, vascular therapy